AKC Awards Imulan Atopic Dermatitis Grant

The AKCCHF granted money to Imulan Bio Therapeutics LLC to develop a new diagnostic method for canine atopic dermatitis.

Imulan BioTherapeutics LLC of Prescott, Ariz., received a grant from the American Kennel Club Canine Health Foundation to develop a diagnostic method for canine atopic dermatitis.

The grant is based on Imulan’s T-Cell Receptor peptide technology platform, the same platform being used to develop a therapeutic vaccine for canine atopic dermatitis.

“We are grateful to the American Kennel Club for its research support for diseases like atopic dermatitis,” said Daniel Gingerich, DVM, chief scientific officer of Imulan. “This project will examine immunological markers in blood to try and better identify patients with atopic dermatitis. If successful, Imulan’s atopic dermatitis diagnostic could be available from Imulan’s reference laboratory early next year.”

Canine atopic dermatitis affects up to 5 percent of the dog population, according to Imulan. Clinical signs include itching and an increase in topical skin infections such as staphylococcal pyoderma.

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.